[
    [
        {
            "time": "",
            "original_text": "东莞证券----医药生物行业2020年疫苗批签发总结：热门大品种持续放量关注自研能力强的疫苗龙头【行业研究】",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "热门大品种",
                    "自研能力",
                    "疫苗龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "东莞证券----医药生物行业2020年疫苗批签发总结：热门大品种持续放量关注自研能力强的疫苗龙头【行业研究】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "13价肺炎疫苗实际销量减少178万支，净利润同比却增6倍，沃森生物如何做到的",
            "features": {
                "keywords": [
                    "13价肺炎疫苗",
                    "销量减少",
                    "净利润增长",
                    "沃森生物"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "13价肺炎疫苗实际销量减少178万支，净利润同比却增6倍，沃森生物如何做到的",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "百克生物2019营收9.8亿销售费4.5亿 代理商涉5起行贿 其他违规处罚",
            "features": {
                "keywords": [
                    "百克生物",
                    "营收",
                    "销售费用",
                    "代理商",
                    "行贿",
                    "违规处罚"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百克生物2019营收9.8亿销售费4.5亿 代理商涉5起行贿 其他违规处罚",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药生物近七成公司年报预喜 机构看好行业长期投资价值",
            "features": {
                "keywords": [
                    "医药生物",
                    "年报预喜",
                    "长期投资价值"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物近七成公司年报预喜 机构看好行业长期投资价值",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]